• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卫生经济学与欧洲肾脏最佳实践——是否到了将卫生经济学纳入欧洲循证指南制定的时候了?

Health economics and European Renal Best Practice--is it time to bring health economics into evidence-based guideline production in Europe?

机构信息

Center for Medical Statistics, Informatics and Intelligent Systems (CeMSIIS), Section for Clinical Biometrics, Medical University of Vienna, Vienna, Austria Department of Nephrology and Transplantation, KH Elisabethinen, Linz, Austria ERBP, European Renal Best Practice, Methods Support Team, Ghent University Hospital, Ghent, Belgium.

ERBP, European Renal Best Practice, Ghent University Hospital, Ghent, Belgium Nephrology Unit, Ghent University Hospital, Ghent, Belgium.

出版信息

Nephrol Dial Transplant. 2014 Nov;29(11):1994-7. doi: 10.1093/ndt/gft369. Epub 2013 Sep 5.

DOI:10.1093/ndt/gft369
PMID:24009293
Abstract

Medical management of patients with kidney disease is complex and resource intensive. In times of limited health care budgets, economic evaluations have become more important over the past few years in identifying interventions with a beneficial cost-effectiveness to maximize the benefits served from the available resources. However, integrating evidence from health-economic evaluations into clinical practice guidelines remains a challenge. European Renal Best Practice (ERBP), the official guideline body of the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) herewith presents some lines of thought that need consideration in the discussion on incorporating health-economic considerations into clinical guideline development.

摘要

肾脏疾病患者的医学管理复杂且资源密集。在医疗保健预算有限的情况下,过去几年,经济评估在确定具有成本效益的干预措施方面变得更加重要,这些干预措施可以最大限度地从现有资源中获益。然而,将健康经济评估的证据纳入临床实践指南仍然是一个挑战。欧洲肾脏最佳实践(ERBP)是欧洲肾脏协会-欧洲透析与移植协会(ERA-EDTA)的官方指南机构,本文提出了在讨论将健康经济考虑因素纳入临床指南制定时需要考虑的一些思路。

相似文献

1
Health economics and European Renal Best Practice--is it time to bring health economics into evidence-based guideline production in Europe?卫生经济学与欧洲肾脏最佳实践——是否到了将卫生经济学纳入欧洲循证指南制定的时候了?
Nephrol Dial Transplant. 2014 Nov;29(11):1994-7. doi: 10.1093/ndt/gft369. Epub 2013 Sep 5.
2
Incorporating considerations of cost-effectiveness, affordability, and resource implications in guideline development: article 6 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.将成本效益、可负担性和资源影响因素纳入指南制定中:COPD 指南制定中整合和协调工作的第 6 条。美国胸科学会/欧洲呼吸学会官方研讨会报告。
Proc Am Thorac Soc. 2012 Dec;9(5):251-5. doi: 10.1513/pats.201208-059ST.
3
European Renal Best Practice (ERBP) Guideline development methodology: towards the best possible guidelines.欧洲肾脏最佳实践(ERBP)指南制定方法:迈向尽可能最佳的指南。
Nephrol Dial Transplant. 2014 Apr;29(4):731-8. doi: 10.1093/ndt/gft407. Epub 2013 Sep 29.
4
A survey on the methodological processes and policies of renal guideline groups as a first step to harmonize renal guidelines.一项关于肾脏指南制定小组的方法学流程和政策的调查,作为协调肾脏指南的第一步。
Nephrol Dial Transplant. 2015 Jul;30(7):1066-74. doi: 10.1093/ndt/gfu288. Epub 2014 Sep 9.
5
European best practice quo vadis? From European Best Practice Guidelines (EBPG) to European Renal Best Practice (ERBP).欧洲最佳实践何去何从?从《欧洲最佳实践指南》(EBPG)到《欧洲肾脏最佳实践》(ERBP)。
Nephrol Dial Transplant. 2008 Jul;23(7):2162-6. doi: 10.1093/ndt/gfn238. Epub 2008 May 9.
6
What guidelines should or should not be: implications for guideline production.应该遵循或不应该遵循哪些指南:对指南制定的启示。
Nephrol Dial Transplant. 2013 Aug;28(8):1980-4. doi: 10.1093/ndt/gft291. Epub 2013 Aug 29.
7
Bridging the gap between what is known and what we do in renal medicine: improving implementability of the European Renal Best Practice guidelines.弥合已知与我们在肾脏医学中实践之间的差距:提高欧洲肾脏最佳实践指南的实施性。
Nephrol Dial Transplant. 2014 May;29(5):951-7. doi: 10.1093/ndt/gft496. Epub 2013 Dec 17.
8
Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) guidelines on kidney transplantation: a European Renal Best Practice (ERBP) position statement.支持肾脏病改善全球结局组织(KDIGO)关于肾移植的指南:欧洲肾脏最佳实践(ERBP)立场声明。
Nephrol Dial Transplant. 2011 Jul;26(7):2099-106. doi: 10.1093/ndt/gfr169. Epub 2011 May 9.
9
[Theoretical implications of health economic evaluations in an Austrian context].[奥地利背景下卫生经济评估的理论意义]
Wien Med Wochenschr. 2006 Dec;156(23-24):622-7. doi: 10.1007/s10354-006-0359-5.
10
European Renal Best Practice Guideline on kidney donor and recipient evaluation and perioperative care.欧洲肾脏最佳实践指南:肾脏供体与受体评估及围手术期护理
Nephrol Dial Transplant. 2015 Nov;30(11):1790-7. doi: 10.1093/ndt/gfu216. Epub 2014 Jul 9.

引用本文的文献

1
The role of health economic evidence in clinical practice guidelines for colorectal cancer: a comparative analysis across countries.健康经济证据在结直肠癌临床实践指南中的作用:一项跨国比较分析。
J Comp Eff Res. 2025 Apr;14(4):e240226. doi: 10.57264/cer-2024-0226. Epub 2025 Feb 19.
2
Informed decision-making in delivery of dialysis: combining clinical outcomes with sustainability.透析治疗中的知情决策:将临床结果与可持续性相结合。
Clin Kidney J. 2021 Dec 27;14(Suppl 4):i98-i113. doi: 10.1093/ckj/sfab193. eCollection 2021 Dec.
3
Health Technology Assessment of a new water quality monitoring technology: Impact of automation, digitalization and remoteness in dialysis units.
新水质监测技术的卫生技术评估:自动化、数字化和远程化对透析单位的影响。
PLoS One. 2021 Feb 25;16(2):e0247450. doi: 10.1371/journal.pone.0247450. eCollection 2021.
4
Reducing the costs of chronic kidney disease while delivering quality health care: a call to action.降低慢性肾脏病的成本,同时提供优质的医疗保健:行动呼吁。
Nat Rev Nephrol. 2017 Jul;13(7):393-409. doi: 10.1038/nrneph.2017.63. Epub 2017 May 30.
5
Building on evidence to improve patient care.基于证据改善患者护理。
Pediatr Nephrol. 2017 Dec;32(12):2193-2202. doi: 10.1007/s00467-016-3554-7. Epub 2016 Dec 9.
6
Incorporating cost-effectiveness data in a fair process for priority setting efforts Comment on "Use of cost-effectiveness data in priority setting decisions: experiences from the national guidelines for heart diseases in Sweden".将成本效益数据纳入优先级设置工作的公平流程中——对“在优先级设置决策中使用成本效益数据:瑞典心脏病国家指南的经验”的评论。
Int J Health Policy Manag. 2015 Apr 11;4(7):483-5. doi: 10.15171/ijhpm.2015.81.
7
Physical exercise programs in CKD: lights, shades and perspectives [corrected].慢性肾脏病中的体育锻炼计划:亮点、不足与展望[已修正]
J Nephrol. 2015 Apr;28(2):143-50. doi: 10.1007/s40620-014-0169-6. Epub 2015 Feb 3.
8
Economic evaluation of dialysis therapies.透析疗法的经济学评价。
Nat Rev Nephrol. 2014 Nov;10(11):644-52. doi: 10.1038/nrneph.2014.145. Epub 2014 Aug 26.